PUBMED FOR HANDHELDS

Journal Abstract Search


625 related items for PubMed ID: 15922454

  • 1. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome.
    Jerjes WK, Cleare AJ, Wessely S, Wood PJ, Taylor NF.
    J Affect Disord; 2005 Aug; 87(2-3):299-304. PubMed ID: 15922454
    [Abstract] [Full Text] [Related]

  • 2. Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome.
    Jerjes WK, Peters TJ, Taylor NF, Wood PJ, Wessely S, Cleare AJ.
    J Psychosom Res; 2006 Feb; 60(2):145-53. PubMed ID: 16439267
    [Abstract] [Full Text] [Related]

  • 3. Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome.
    Jerjes WK, Taylor NF, Peters TJ, Wessely S, Cleare AJ.
    Psychosom Med; 2006 Feb; 68(4):578-82. PubMed ID: 16868267
    [Abstract] [Full Text] [Related]

  • 4. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A, Hudson M, Jerjes W, Cleare AJ.
    Psychosom Med; 2005 Feb; 67(3):433-40. PubMed ID: 15911907
    [Abstract] [Full Text] [Related]

  • 5. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome.
    Nater UM, Youngblood LS, Jones JF, Unger ER, Miller AH, Reeves WC, Heim C.
    Psychosom Med; 2008 Apr; 70(3):298-305. PubMed ID: 18378875
    [Abstract] [Full Text] [Related]

  • 6. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia).
    Young AH, Sharpe M, Clements A, Dowling B, Hawton KE, Cowen PJ.
    Biol Psychiatry; 1998 Feb 01; 43(3):236-7. PubMed ID: 9494707
    [Abstract] [Full Text] [Related]

  • 7. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test.
    Papadopoulos A, Ebrecht M, Roberts AD, Poon L, Rohleder N, Cleare AJ.
    J Affect Disord; 2009 Jan 01; 112(1-3):289-94. PubMed ID: 18573538
    [Abstract] [Full Text] [Related]

  • 8. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
    Inder WJ, Prickett TC, Mulder RT.
    Clin Endocrinol (Oxf); 2005 Mar 01; 62(3):343-8. PubMed ID: 15730417
    [Abstract] [Full Text] [Related]

  • 9. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
    Van Den Eede F, Moorkens G, Hulstijn W, Van Houdenhove B, Cosyns P, Sabbe BG, Claes SJ.
    Psychol Med; 2008 Jul 01; 38(7):963-73. PubMed ID: 17803834
    [Abstract] [Full Text] [Related]

  • 10. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J, Rohleder N, Heitz V, Engert V, Schad T, Schürmeyer TH, Ehlert U.
    Psychoneuroendocrinology; 2005 Feb 01; 30(2):188-98. PubMed ID: 15471616
    [Abstract] [Full Text] [Related]

  • 11. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.
    Gaab J, Engert V, Heitz V, Schad T, Schürmeyer TH, Ehlert U.
    J Psychosom Res; 2004 Apr 01; 56(4):419-24. PubMed ID: 15094026
    [Abstract] [Full Text] [Related]

  • 12. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome.
    Crofford LJ, Young EA, Engleberg NC, Korszun A, Brucksch CB, McClure LA, Brown MB, Demitrack MA.
    Brain Behav Immun; 2004 Jul 01; 18(4):314-25. PubMed ID: 15157948
    [Abstract] [Full Text] [Related]

  • 13. Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome.
    Jerjes WK, Taylor NF, Wood PJ, Cleare AJ.
    Psychoneuroendocrinology; 2007 Feb 01; 32(2):192-8. PubMed ID: 17276605
    [Abstract] [Full Text] [Related]

  • 14. The role of hypocortisolism in chronic fatigue syndrome.
    Nijhof SL, Rutten JM, Uiterwaal CS, Bleijenberg G, Kimpen JL, Putte EM.
    Psychoneuroendocrinology; 2014 Apr 01; 42():199-206. PubMed ID: 24636516
    [Abstract] [Full Text] [Related]

  • 15. Basal hypercortisolism and trauma in patients with psychogenic nonepileptic seizures.
    Bakvis P, Spinhoven P, Giltay EJ, Kuyk J, Edelbroek PM, Zitman FG, Roelofs K.
    Epilepsia; 2010 May 01; 51(5):752-9. PubMed ID: 19889016
    [Abstract] [Full Text] [Related]

  • 16. Diurnal cortisol levels and cortisol response in youths with obsessive-compulsive disorder.
    Gustafsson PE, Gustafsson PA, Ivarsson T, Nelson N.
    Neuropsychobiology; 2008 May 01; 57(1-2):14-21. PubMed ID: 18424906
    [Abstract] [Full Text] [Related]

  • 17. Sex differences in hypothalamic-pituitary-adrenal axis function in patients with chronic pain syndrome.
    Turner-Cobb JM, Osborn M, da Silva L, Keogh E, Jessop DS.
    Stress; 2010 Jul 01; 13(4):292-300. PubMed ID: 20536331
    [Abstract] [Full Text] [Related]

  • 18. Diurnal cortisol decline is related to coronary calcification: CARDIA study.
    Matthews K, Schwartz J, Cohen S, Seeman T.
    Psychosom Med; 2006 Jul 01; 68(5):657-61. PubMed ID: 17012518
    [Abstract] [Full Text] [Related]

  • 19. Cortisol awakening response is elevated in acute coronary syndrome patients with type-D personality.
    Whitehead DL, Perkins-Porras L, Strike PC, Magid K, Steptoe A.
    J Psychosom Res; 2007 Apr 01; 62(4):419-25. PubMed ID: 17383493
    [Abstract] [Full Text] [Related]

  • 20. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia.
    McLean SA, Williams DA, Harris RE, Kop WJ, Groner KH, Ambrose K, Lyden AK, Gracely RH, Crofford LJ, Geisser ME, Sen A, Biswas P, Clauw DJ.
    Arthritis Rheum; 2005 Nov 01; 52(11):3660-9. PubMed ID: 16258904
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.